IVF for gender selection: how does it work and what are your options? 

For couples who would like a boy or a girl, fertility treatment can now identify the chromosomal sex of embryos before pregnancy.

With IVF and genetic testing, embryos are examined in the laboratory so the fertility team can identify their chromosomal sex before an embryo is chosen for transfer. This is known as gender selection or family balancing.

In Egypt, gender selection is offered through IVF and embryo genetic testing, as part of a medically supervised fertility treatment plan.

So how does the process work, what does genetic testing involve, and what should you expect?

What is IVF for gender selection?

IVF for gender selection combines in vitro fertilisation (IVF) with preimplantation genetic testing (PGT) to identify the chromosomal sex of embryos before they are transferred to the uterus.

Eggs are collected from the ovaries and fertilised with sperm in the laboratory. As the embryos develop, suitable embryos are genetically tested to examine their chromosomes, including the sex chromosomes.

Embryos with XX chromosomes are chromosomally female; embryos with XY chromosomes are chromosomally male.

Once the results are available, the fertility team identifies embryos of the desired chromosomal sex and assesses their suitability for transfer.

The approach is also called family balancing, particularly when couples want a child of a different sex from their existing children.

Genetic testing identifies chromosomal sex. It does not predict a child’s future gender identity.

How does gender selection through IVF work?

Gender selection follows the main stages of an IVF cycle, with one added step: embryo biopsy and genetic testing.

1. Ovarian stimulation

Hormonal medication stimulates the ovaries to produce several follicles containing eggs. The fertility team monitors the response with ultrasound scans and, when appropriate, blood tests. The aim is to collect a good number of mature eggs. Patients who find daily injections difficult can ask about No-Needle IVF.

2. Egg retrieval

When the follicles are ready, the eggs are collected in a short procedure, usually under sedation. The laboratory then checks which eggs are mature and suitable for fertilisation.

3. Fertilisation through IVF or ICSI

The eggs are fertilised with sperm in the laboratory, by conventional IVF or by intracytoplasmic sperm injection (ICSI), depending on the couple’s medical circumstances. The embryos are then cultured and monitored as they develop.

4. Embryo biopsy and genetic testing

When suitable embryos reach the blastocyst stage, usually on day five or six, a few cells are taken from the outer layer of the embryo. These cells are tested to examine their chromosomes, including the sex chromosomes, which identifies the chromosomal sex of each tested embryo.

5. Embryo selection

When the results are ready, the fertility team reviews them and identifies embryos of the desired chromosomal sex. Each embryo’s overall suitability for transfer is assessed from the genetic results and clinical information.

6. Embryo transfer

A suitable embryo is transferred into the uterus. In many cases, embryos are frozen while the genetic results are awaited, and the transfer takes place in a later frozen embryo transfer cycle. The timing depends on your treatment plan and your specialist’s advice.

How does genetic testing identify the baby’s sex?

The technique is called preimplantation genetic testing (PGT). It lets specialists examine genetic material from IVF embryos before deciding which embryo to transfer.

The laboratory analyses the chromosomes in the sampled cells, including the sex chromosomes, which are generally XX or XY. The results therefore show the chromosomal sex of each tested embryo.

Genetic testing has limitations. The sampled cells may not represent every cell in the embryo, particularly in chromosomal mosaicism, and results are occasionally inconclusive. For this reason, results should always be interpreted by qualified laboratory and fertility specialists.

What is the difference between PGT-A and PGT-M?

There are different types of preimplantation genetic testing, depending on the reason for testing.

PGT-A: chromosome screening

PGT-A stands for preimplantation genetic testing for aneuploidy. It checks whether the sampled embryo cells have the expected number of chromosomes. The analysis also identifies the sex chromosomes, so PGT-A shows the chromosomal sex of an embryo while assessing its chromosome number.

PGT-A does not guarantee implantation or pregnancy, and it is not recommended routinely for every IVF patient. Its benefits and limitations should be discussed with a fertility specialist. Read more in PGT-A and IVF: when it is recommended.

PGT-M: testing for inherited conditions

PGT-M stands for preimplantation genetic testing for monogenic disorders. It is used when one or both genetic parents carry a specific inherited condition that could be passed on to their child.

Some inherited conditions are linked to the sex chromosomes. In these cases, embryo testing can help identify affected embryos. PGT-M tests for a specific genetic disorder rather than simply identifying whether an embryo is chromosomally male or female.

The right test depends on the reason for treatment and the family’s genetic history.

Who can consider IVF for gender selection?

Couples consider IVF for gender selection for different reasons, including family balancing and concerns about inherited genetic conditions. A fertility specialist assesses your circumstances before recommending a plan. The assessment may cover:

• The woman’s age and ovarian reserve
• Previous pregnancy and fertility history
• Previous IVF cycles, if any
• The man’s semen analysis
• Any known inherited genetic conditions
• The expected response to ovarian stimulation
• The number of embryos likely to be available for testing

Not every IVF cycle produces embryos suitable for genetic testing, and not every patient will have an embryo of the desired chromosomal sex. An individual consultation establishes what is realistic before treatment begins.

What are the chances of success?

There are two separate outcomes to consider. The first is identifying the chromosomal sex of an embryo through genetic testing. The second is achieving a pregnancy and, ultimately, a live birth.

Genetic testing can identify the sex chromosomes in the sampled cells, but that does not guarantee an embryo of the desired sex will be available and suitable for transfer. The chances depend on:

• The woman’s age
• Ovarian reserve and response to stimulation
• The number of eggs retrieved
• Fertilisation rates
• Embryo development and quality
• The genetic testing results
• Uterine health and other fertility factors

For example, a patient may have several embryos available for testing, but some may not reach the blastocyst stage or may not be suitable for transfer.

It is important to separate the accuracy of genetic testing from the success rate of the IVF cycle itself. No fertility treatment can guarantee a pregnancy or live birth.

What should you consider before starting?

Before beginning treatment, make sure you understand the process, the testing involved and the possible outcomes. A consultation should answer:

• Which type of genetic testing will be used?
• Can the test identify the chromosomal sex of the embryos?
• How many embryos are likely to be available for testing?
• What happens if no suitable embryo of the desired sex is obtained?
• Will the embryos be frozen while the genetic results are awaited?
• How long will the treatment take?
• What are the additional costs of genetic testing?
• What are the risks and limitations of embryo biopsy?
• What are the chances of a successful pregnancy?
• What follow-up care will be needed?

If there is a family history of an inherited genetic condition, genetic counselling may also be recommended. Understanding the plan in advance helps couples make informed decisions and set realistic expectations.

Considering IVF for gender selection in Egypt?

Egypt is an option for couples exploring IVF with embryo genetic testing. Gender selection is performed through IVF combined with preimplantation genetic testing, subject to the applicable clinical and regulatory requirements. If you are travelling to Egypt, understand the treatment arrangements before making travel plans.

Can you arrange a consultation before travelling?

Yes. An initial online consultation lets Dr. Omar review your medical history, previous investigations and goals. You may be asked for previous IVF reports, blood tests, ultrasound findings and semen analysis results, where available. Further investigations may be needed before a final plan is confirmed.

How long does the process take?

The timeline depends on your response to ovarian stimulation, embryo development and the genetic testing. A typical cycle involves stimulation, egg retrieval, fertilisation, embryo development, biopsy and testing. If embryos are frozen while the results are awaited, the transfer usually takes place in a later cycle. The fertility team should explain the expected timeline and number of visits before you travel.

Can you return home after egg retrieval?

In many cases, yes. Patients can often return home after egg retrieval and complete a frozen embryo transfer on a later visit, depending on their treatment plan and medical suitability. This suits international patients who cannot stay in Egypt for the whole process.

What happens after the genetic results are available?

The fertility team reviews the results and discusses which embryos may be suitable for transfer. The next step depends on the genetic findings, embryo suitability and your clinical circumstances. Ask how results and follow-up consultations will be coordinated if you return home between stages.